AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 178 filers reported holding AXSOME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.98 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,706,854 | -1.0% | 95,963 | +1.8% | 0.02% | 0.0% |
Q2 2023 | $6,774,817 | +24.0% | 94,278 | +6.5% | 0.02% | +17.6% |
Q1 2023 | $5,461,456 | -20.2% | 88,545 | -0.2% | 0.02% | -26.1% |
Q4 2022 | $6,844,439 | +15.9% | 88,739 | -33.6% | 0.02% | +9.5% |
Q3 2022 | $5,903,000 | +25.7% | 133,705 | +3.9% | 0.02% | +23.5% |
Q2 2022 | $4,695,000 | -11.8% | 128,677 | -0.0% | 0.02% | +13.3% |
Q1 2022 | $5,323,000 | +17.0% | 128,692 | +6.9% | 0.02% | +50.0% |
Q4 2021 | $4,550,000 | +86.6% | 120,440 | +62.8% | 0.01% | +66.7% |
Q3 2021 | $2,438,000 | -50.9% | 73,969 | +0.5% | 0.01% | -53.8% |
Q2 2021 | $4,965,000 | +24.1% | 73,598 | +4.2% | 0.01% | +18.2% |
Q1 2021 | $4,001,000 | -31.9% | 70,664 | -2.0% | 0.01% | -31.2% |
Q4 2020 | $5,875,000 | +14.7% | 72,107 | +0.3% | 0.02% | -11.1% |
Q3 2020 | $5,124,000 | +35.4% | 71,910 | +56.3% | 0.02% | +20.0% |
Q2 2020 | $3,785,000 | +81.1% | 46,005 | +29.5% | 0.02% | +25.0% |
Q1 2020 | $2,090,000 | – | 35,521 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |